Chunying Shen
138 Yixueyuan Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Integrating Pretreatment Circulating Tumor HPV DNA and Tumor Volume for Risk Stratification in HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Journal: Cancers
Published: June 01, 2026
Validation of the 9th edition cTNM classification for HPV-positive oropharyngeal carcinoma in a non-endemic Chinese cohort.
Journal: Clinical and translational radiation oncology
Published: April 07, 2026
Pretreatment FDG PET in prognosis of locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
Journal: International journal of medical sciences
Published: October 29, 2024
Liquid biopsy with plasma Epstein-Barr virus DNA characterizes biological relapse for the prediction of cancer recurrence in non-disseminated nasopharyngeal carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 20, 2024
MR radiomics unveils neoadjuvant chemo-responsiveness with insights into selective treatment de-intensification in HPV-positive oropharyngeal carcinoma.
Journal: Oral oncology
Published: May 03, 2024
Anlotinib reversed resistance to PD-1 inhibitors in recurrent and metastatic head and neck cancers: a real-world retrospective study.
Journal: Cancer immunology, immunotherapy : CII
Published: April 22, 2024
Prediction of Drug-Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: April 23, 2023
Tumor cell-derived exosomal miR-193b-3p promotes tumor-associated macrophage activation to facilitate nasopharyngeal cancer cell invasion and radioresistances.
Journal: Heliyon
Published: April 19, 2023
Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IChoice-01).
Journal: International journal of radiation oncology, biology, physics
Published: March 05, 2023
Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer.
Journal: Cancer medicine
Published: September 23, 2022
Last Updated: 09/26/2026